Are you at the American Diabetes Association’s 84th Scientific Sessions this weekend? Come visit us at booth 521 to find out how the iLet Bionic Pancreas helps reduce the work and stress of diabetes for patients.
Beta Bionics
Biotechnology
Irvine, CA 11,590 followers
Working to improve the lives of people living with diabetes and help reduce the data and decision-making overload.
About us
Beta Bionics is a medical technology company focused on the design, development, and commercialization of the iLet Bionic Pancreas and the bihormonal configuration. The iLet is the first and only insulin delivery system that does not require carb counting*, bolusing, correction factors, or pre-set basal rates. The only number needed to get started with the iLet Bionic Pancreas is a user’s weight – the iLet does the rest. The iLet lets users “Go Bionic” with their diabetes management. Beta Bionics is a for-profit, public benefit corporation and Certified B Corporation. Since its founding in 2015, its mission has been to help improve health outcomes and the quality of life of children and adults living with diabetes and other conditions of glycemic dysregulation. *Users must be carb aware.
- Website
-
http://www.betabionics.com
External link for Beta Bionics
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Irvine, CA
- Type
- Privately Held
- Founded
- 2015
- Specialties
- the iLet Bionic Pancreas
Locations
-
Primary
Get directions
11 Hughes
Irvine, CA 92618, US
-
Get directions
300 Baker Avenue
Suite 300
Concord, Massachusetts 01742, US
Employees at Beta Bionics
Updates
-
Exciting news! iLet users can now view their iLet home screen in real time using the iLet Mobile App and pause insulin delivery when they are disconnected from the iLet for activities such as showering, exercise or swimming. For instructions on how to update the iLet App, visit: https://lnkd.in/gGjg64zh
-
-
"In our early trials, some of our favorite quotes were things like, 'I forgot I had diabetes,' and that's really the goal of a product like this," Beta Bionics CEO Sean Saint said in a recent podcast about our partnership with Xeris Pharmaceuticals, Inc. Listen to the Risely Health podcast below.
-
Today, we're celebrating one year since we announced FDA 510(k) clearance and the commercial launch of the iLet Bionic Pancreas. We're proud to have helped so many iLet users simplify their diabetes management over the past year. Read some of their stories below. *Individual results may vary. Safety info: https://lnkd.in/gduF95KP
-
-
Big news! We’re excited to announce that we’re partnering with Xeris Pharmaceuticals, Inc. on the development and commercialization of a new and unique formulation of liquid stable glucagon for use in a bi-hormonal pump.
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
newswire.com
-
Interested in learning about the iLet Bionic Pancreas? Join us for our upcoming webinars presented by Ed Damiano, PhD, Founder and Executive Chairman and Steven Russell, MD, PhD, Chief Medical Officer at Beta Bionics. Register at: https://lnkd.in/gaEurCzA
-
-
We're proud to be featured on Fierce Medtech's latest Fierce 15 list, an annual report that recognizes the most innovative private medtech companies in the industry.
Fierce Medtech's Fierce 15 is now live. This year's winners offer tools to illuminate the unseen, AI that captures patterns in the noise, diagnostics that help erase doubt, and ways to better understand the molecular machinery behind both life and disease.
Fierce Medtech's Fierce 15 of 2023
fiercebiotech.com
-
Beta Bionics CEO Sean Saint is featured on this episode of NYSE's The Cure(ious) talking about workplace culture. Watch here: https://lnkd.in/dP6UmjFw
All things leadership 🎙️ We’re curious about the advice of some of the greatest leaders in healthcare. Tune into this episode of The Cure(ious) https://lnkd.in/dP6UmjFw Featuring: Cathy Gao of Sapphire Ventures, Gina Bartasi of Kindbody, Jak Knowles of Affini-T Therapeutics, Jakob Dupont of Sofinnova Investments, Paul Biondi of Flagship Pioneering, Sean Saint of Beta Bionics, Thomas Oxley of Synchron, Todd Powell of RefleXion Medical
-
Interested in learning about the iLet Bionic Pancreas Pivotal Trial? Join us tomorrow for a live webinar hosted by Ed Damiano, PhD, Founder and Executive Chairman and Steven Russell, MD, PhD, Chief Medical Officer at Beta Bionics. Register at:
Register for The iLet Pivotal Trial: Patient Profiles and Successes Webinar
betabionics.zoom.us
-
What do you believe is the single most pressing healthcare challenge? Beta Bionics CEO Sean Saint is featured in the NYSE's The Cure(ious) series answering this and other questions. Watch now: https://lnkd.in/ehvYf_7R
Healthcare innovations, the patient experience, AI and more. Some of the greatest minds in healthcare give insight to the future of the industry on The Cure(ious). Part 1: https://lnkd.in/ehvYf_7R Part 2: https://lnkd.in/erUUrfUK Featuring: Liang Schweizer of HiFiBiO Therapeutics, Paul Biondi of Flagship Pioneering, Robin Ann McIntosh of Workit Health, Russell Glass of Headspace, Sean Duffy of Omada Health, Amanda Eisel of Zelis, Cathy Gao of Sapphire Ventures, Farzad Mostashari of Aledade, Inc., Gina Bartasi of Kindbody, Kevin Caldwell of Ossium Health, Sean Saint of Beta Bionics, Greg Verdine of LifeMine Therapeutics, Shehnaaz Suliman, M.D. (MB ChB), M.B.A., M.Phil. of ReCode Therapeutics, Jacob Becraft, PhD, of Strand Therapeutics, Fabrice Chouraqui of Cellarity, David Stein of Babson Diagnostics